Cargando…
Preliminary evaluation of a candidate international reference for Epstein–Barr virus capsid antigen immunoglobulin A in China
BACKGROUND: The detection of the Epstein–Barr capsid antigen (VCA) immunoglobulin A (IgA) is widely used in the diagnosis of nasopharyngeal carcinoma (NPC), but a reference standard for evaluating the presence of VCA-IgA is not yet available. Therefore, a reference standard is urgently needed for a...
Autores principales: | Chen, Hao, Zhong, Qiaohua, Wu, Xiaobin, Ding, Yanling, Chen, Qi, Xue, Ning, Xu, Yiwei, Chen, Shulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191735/ https://www.ncbi.nlm.nih.gov/pubmed/32368250 http://dx.doi.org/10.1186/s13027-020-00294-8 |
Ejemplares similares
-
Positivity of both plasma Epstein–Barr virus DNA and serum Epstein–Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma
por: Zhao, Fei-Peng, et al.
Publicado: (2014) -
CryoEM structure of the tegumented capsid of Epstein-Barr virus
por: Li, Zhihai, et al.
Publicado: (2020) -
IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
por: Ho, H. C., et al.
Publicado: (1977) -
Expression of Epstein-Barr Viral Capsid, Complement Fixing, and Nuclear Antigens in Stationary and Exponential Phase Cultures
por: Miller, George, et al.
Publicado: (1974) -
Factors affecting serum IgA antibody to Epstein-Barr viral capsid antigens in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1978)